SGK1 inhibitor

Advertisement

cGxPJobs Banner

Thryv Therapeutics Targets LQTS with THRV-1268 Trial Launch

San Francisco, California, USA – April 22, 2026 In a significant advancement for rare cardiac disease therapeutics, Thryv Therapeutics...

By cGxPwire Editor
April 23, 2026

Read More

Advertisement

cGxPJobs

Directory